Susanne Buschke

Tumor Necrosis Factor-α and Angiostatin Are Mediators of Endothelial Cytotoxicity in Bronchoalveolar Lavages of Patients with Acute Respiratory Distress Syndrome

Jürg Hamacher, Rudolf Lucas, H.R. Lijnen et al. · American Journal of Respiratory and Critical Care Medicine · 2002 · 106 citations

Veterinary Medicine, Immunology, Pathobiology +17

Bioequivalence, safety and immunogenicity of BI 695501, an adalimumab biosimilar candidate, compared with the reference biologic in a randomized, double-blind, active comparator phase I clinical study (VOLTAIRE®-PK) in healthy subjects

Christopher Wynne, Mario Altendorfer, Ivo Sonderegger et al. · Expert Opinion on Investigational Drugs · 2016 · 59 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

A decisive function of transforming growth factor-β/Smad signaling in tissue morphogenesis and differentiation of human HaCaT keratinocytes

Susanne Buschke, Hans-Jürgen Stark, Ana Cerezo et al. · Molecular Biology of the Cell · 2011 · 46 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +14

Pharmacokinetics of afatinib in subjects with mild or moderate hepatic impairment

David Schnell, Susanne Buschke, Holger Fuchs et al. · Cancer Chemotherapy and Pharmacology · 2014 · 43 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours

Johann S. de Bono, Chia‐Chi Lin, Li‐Tzong Chen et al. · British Journal of Cancer · 2020 · 42 citations · Full text

Medicine, Oncology, Pharmacology +13